Maharashtra Chief Minister Uddhav Thackeray on Monday launched convalescent plasma therapy-cum- trial project for treatment of critical COVID-19 patients with a state medical education department official calling it the largest initiative of its kind in the world.
Convalescent plasma therapy, also called passive antibody therapy, seeks to obtain plasma from the blood of people who have recovered from the infection to inject into patients undergoing treatment.
“The project, titled ‘Platina’, is the largest convalescent plasma therapy-cum-trial project in the world.
With it, we intend to save lives of some 500 critical COVID-19 patients. The trial will be held in 17 medical colleges under the department of medical education and drugs, and four BMC- run colleges in Mumbai,” the official said.
All critical patients will receive two doses of 200 ml convalescent plasma free of cost, he added.
You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in
Show Less Plan
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Faster pages
Move smoothly between articles as our pages load instantly.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Personalised recommendations
A select list of articles that match your interests and tastes.
Briefing
We brief you on the latest and most important developments, three times a day.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
